ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.
NCT00051493 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2006-07-19
Summary
The purpose of this study is to evaluate the effects (good and bad) of LY231514 (ALIMTA) and Carboplatin on you and your non-small cell lung cancer.
Conditions
- Carcinoma, Non-Small-Cell Lung
Interventions
- DRUG
-
ALIMTA
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-04-30
- Completion
- 2002-12-31
Countries
- United States
Study Locations
More Related Trials
-
Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2
NCT01836575 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
NCT02941601 ·Status: WITHDRAWN ·Phase: PHASE2
-
Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
NCT00097214 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer
NCT00363415 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC
NCT00251524 ·Status: COMPLETED ·Phase: PHASE2
-
NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer
NCT00749346 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00003117 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer
NCT00112346 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer
NCT04736173 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
NCT00553462 ·Status: COMPLETED ·Phase: PHASE2
-
Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer
NCT00005059 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)
NCT01100931 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
NCT00918203 ·Status: COMPLETED ·Phase: PHASE2
-
ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer
NCT03402880 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.
NCT00042679 ·Status: COMPLETED ·Phase: PHASE2
-
Anaplastic Lymphoma Kinase (ALK)-Positive Non-small Cell Lung Cancer (NSCLC) Post-alectinib Treatment Patterns
NCT04351334 ·Status: COMPLETED
-
Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer
NCT00453154 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned
NCT00191750 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer
NCT01519804 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
NCT01154140 ·Status: COMPLETED ·Phase: PHASE3
-
Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung Cancer
NCT00614822 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of Sintilimab Combined With Gemcitabine/Carboplatin Regimen in the Treatment of Advanced Primary Pulmonary Lymphoepithelioma-like Carcinoma
NCT04312204 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung Cancer
NCT00530621 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma
NCT00212043 ·Status: COMPLETED ·Phase: PHASE2
-
Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
NCT00052338 ·Status: COMPLETED ·Phase: PHASE1